Biomerica, Inc. (BMRA)
Oxford Ledge is still expanding full research coverage of BMRA. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
Global biomedical company developing and marketing diagnostic test kits for disease detection in clinical and point-of-care settings.
SEC filings
- 8-K Entry into material agreement; Creation of direct financial obligation; Financial statements and exhibits 2026-06-04
- 10-Q Quarterly financial report (unaudited) 2026-04-13
- 10-Q Quarterly financial report (unaudited) 2026-01-14
- 8-K Shareholder vote results 2025-12-16
- DEF 14A Proxy statement for shareholder vote 2025-10-20
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for BMRA. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open BMRA in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.